UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Gene therapy – are we ready now?

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-05, Vol.28 (S4), p.35-43

Kaczmarek, Radoslaw

2022

Volltextzugriff (PDF)

The baculovirus-expressed binding region of Plasmodium falciparum EBA-140 ligand and its glycophorin C binding specificity

PloS one, 2015-01, Vol.10 (1), p.e0115437-e0115437

2015

Volltextzugriff (PDF)

Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system

PloS one, 2018-04, Vol.13 (4), p.e0196627-e0196627

2018

Volltextzugriff (PDF)

Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity

PloS one, 2015-02, Vol.10 (2), p.e0116472-e0116472

2015

Volltextzugriff (PDF)

Terapia genowa hemofilii – czy wkrótce będzie możliwe wyleczenie?

Postępy biochemii, 2018-12, Vol.64 (4), p.318-322

Kaczmarek, Radosław

2018

Volltextzugriff (PDF)

Revisiting the “Danger Theory”: Toll-like Receptor 9 Stimulation Triggers Activation of Conventional CD8α+ and Plasmacytoid Dendritic Cells En Route to Enhancing FVIII Inhibitor Formation

Blood, 2020-11, Vol.136 (Supplement 1), p.1-1

2020

Volltextzugriff (PDF)

Factor IX Delivery to the Skin Primes Inhibitor Formation and Sensitizes Hemophilia B Mice to Systemic Factor IX Administration

Blood, 2021-11, Vol.138 (Supplement 1), p.3194-3194

2021

Volltextzugriff (PDF)

Antigen Trafficking and Possibly Intrinsic Immunostimulatory Properties Shape High Immunogenicity of Factor VIII

Blood, 2022-11, Vol.140 (Supplement 1), p.967-968

2022

Volltextzugriff (PDF)

Toll-like Receptor 9 Activation Accelerates Inhibitor Formation in Response to Factor VIII

Blood, 2019-11, Vol.134 (Supplement_1), p.1113-1113

2019

Volltextzugriff (PDF)

Helper T Cell Response to Factor VIII In Vivo Requires Several Anatomically Distinct Types of Antigen Presenting Cells

Blood, 2021-11, Vol.138 (Supplement 1), p.440-440

2021

Volltextzugriff (PDF)

Alternative Approaches to Oral Tolerance Induction to Factor FVIII

Blood, 2020-11, Vol.136 (Supplement 1), p.8-9

2020

Volltextzugriff (PDF)

Professor Elwira Lisowska Celebrates Her 90th Birthday

Archivum Immunologiae et Therapiae Experimentalis, 2020-01, Vol.68 (4)

2020

Volltextzugriff (PDF)

B cell-activating factor modulates the factor VIII immune response in hemophilia A

The Journal of clinical investigation, 2021-04, Vol.131 (8)

2021

Volltextzugriff (PDF)

B cell–activating factor modulates the factor VIII immune response in hemophilia A

The Journal of clinical investigation, 2021-04, Vol.131 (8), p.1-14

2021

Volltextzugriff (PDF)

Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating P(k), P1 and NOR blood group antigens

Biochemical and biophysical research communications, 2016-01, Vol.470 (1), p.168-174

2016

Volltextzugriff (PDF)

Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List

The Lancet. Haematology, 2024-09, Vol.11 (9), p.e638-e640

2024

Volltextzugriff (PDF)

Uniform rotundity of Orlicz function spaces equipped with the ‐Amemiya norm

Mathematische Nachrichten, 2018-07, Vol.291 (10), p.1514-1532

Kaczmarek, Radosław

2018

Volltextzugriff (PDF)

Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating Pk, P1 and NOR blood group antigens

Biochemical and biophysical research communications, 2016-01, Vol.470 (1), p.168-174

2016

Volltextzugriff (PDF)

Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating Pk, P1 and NOR blood group antigens

Biochemical and biophysical research communications, 2016, Vol.470 (29), p.168-174

2016

Volltextzugriff (PDF)

Gene therapy of haemophilia - has the cure come within reach?

Postępy biochemii, 2018-12, Vol.64 (4), p.318-322

Kaczmarek, Radosław

2018

Volltextzugriff (PDF)

Human α1,4-galactosyltransferase (Gb3/CD77 synthase): Expression in insect cells, properties, role of glycans

New biotechnology, 2016-07, Vol.33, p.S123-S123

2016

Volltextzugriff (PDF)

Optimizing Liver Health Before and After Gene Therapy for Hemophilia A

Blood advances, 2024-06

2024

Volltextzugriff (PDF)

Hepatitis C and bleeding disorders in Europe

Journal of Haemophilia Practice, 2018-06, Vol.5 (1), p.50-65

2018

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

ThemaOphthalmology

ThemaPhysical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Gene therapy – are we ready now?

The baculovirus-expressed binding region of Plasmodium falciparum EBA-140 ligand and its glycophorin C binding specificity

Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system

Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity

Terapia genowa hemofilii – czy wkrótce będzie możliwe wyleczenie?

Revisiting the “Danger Theory”: Toll-like Receptor 9 Stimulation Triggers Activation of Conventional CD8α+ and Plasmacytoid Dendritic Cells En Route to Enhancing FVIII Inhibitor Formation

Factor IX Delivery to the Skin Primes Inhibitor Formation and Sensitizes Hemophilia B Mice to Systemic Factor IX Administration

Antigen Trafficking and Possibly Intrinsic Immunostimulatory Properties Shape High Immunogenicity of Factor VIII

Toll-like Receptor 9 Activation Accelerates Inhibitor Formation in Response to Factor VIII

Helper T Cell Response to Factor VIII In Vivo Requires Several Anatomically Distinct Types of Antigen Presenting Cells

Alternative Approaches to Oral Tolerance Induction to Factor FVIII

Professor Elwira Lisowska Celebrates Her 90th Birthday

B cell-activating factor modulates the factor VIII immune response in hemophilia A

B cell–activating factor modulates the factor VIII immune response in hemophilia A

Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating P(k), P1 and NOR blood group antigens

Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List

Uniform rotundity of Orlicz function spaces equipped with the ‐Amemiya norm

Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating Pk, P1 and NOR blood group antigens

Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating Pk, P1 and NOR blood group antigens

Gene therapy of haemophilia - has the cure come within reach?

Human α1,4-galactosyltransferase (Gb3/CD77 synthase): Expression in insect cells, properties, role of glycans

Optimizing Liver Health Before and After Gene Therapy for Hemophilia A

Hepatitis C and bleeding disorders in Europe

Aktive Filter

Suchergebnisse filtern